Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease. Mov Disord Clin Pract 2018;5:627-634. | USF Parkinson's Disease and Movement Disorders Center

Hauser, RA, I Biaggioni, LA Hewitt, and S Vernino. 2018. “Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson Disease. Mov Disord Clin Pract 2018;5:627-634.”. Mov Disord Clin Pract.

Last updated on 10/02/2024